Scientists found that some chemotherapy drugs can activate the innate immune system. In tests of a potential agent called Compound 1, treated cancer cells made toxic molecules called reactive oxygen species. The cells then released signals normally seen in virus infection. This effect is known as viral mimicry.
When researchers put pretreated cancer cells into test animals, the immune system removed them and stayed ready to attack other cancer cells. Scientists now plan to screen existing chemotherapy drugs for viral mimicry and try combinations with immunotherapy.
Difficult words
- chemotherapy — medicine that kills or stops cancer cells
- innate immune system — body's first defense against germs and danger
- activate — make something start to work or act
- reactive oxygen species — harmful oxygen molecules made in cells
- viral mimicry — when cells send signals like a virus
- immunotherapy — treatment that helps the immune system fight disease
- screen — test many drugs to find useful ones
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think combining chemotherapy and immunotherapy could help patients? Why or why not?
- What worries or interests you about tests in animals mentioned in the article?
- Would you like doctors to screen existing drugs for new uses? Why or why not?
Related articles
Gagandeep Kang on Vaccines, Surveillance and Child Health in India
Gagandeep Kang, a leading expert on enteric diseases, urges India to prepare tools to prevent viral outbreaks. She helped develop indigenous rotavirus vaccines, built surveillance networks and now works at the Gates Foundation.
Africa uses AI to strengthen health systems and self-reliance
At the CPHIA conference in Durban, Africa CDC said AI and digital tools can help protect 1.4 billion people, improve surveillance and support primary health care. Data governance, infrastructure and domestic financing are key concerns.
Targeting inflammation as a way to treat depression
A federally funded review and meta-analysis found that anti-inflammatory treatments reduced depressive symptoms and eased anhedonia in people with depression who had high inflammation. The drugs were not FDA-approved for depression and would be used off-label.
New modular CAR-T system controls where and when cells attack
Researchers at the University of Chicago created GA1CAR, a modular CAR-T system that uses short-lived Fab fragments to guide and pause tumor targeting. In animal tests the same cells were redirected to different tumors and remained functional.